Amundi Sells 13,682 Shares of Synopsys, Inc. $SNPS

Amundi lessened its position in shares of Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 0.8% in the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,748,301 shares of the semiconductor company's stock after selling 13,682 shares during the period. Amundi owned approximately 0.91% of Synopsys worth $779,865,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other large investors also recently modified their holdings of the company. BlackRock Inc. acquired a new position in Synopsys during the second quarter worth $7,228,099,000. Mitsubishi UFJ Asset Management Co. Ltd. bought a new position in shares of Synopsys in the second quarter valued at approximately $747,400,000. Norges Bank purchased a new position in shares of Synopsys during the fourth quarter valued at approximately $730,197,000. Bank of New York Mellon Corp purchased a new position in shares of Synopsys during the second quarter valued at approximately $692,074,000. Finally, State Street Corp grew its holdings in Synopsys by 20.6% during the third quarter. State Street Corp now owns 8,760,358 shares of the semiconductor company's stock worth $4,322,273,000 after buying an additional 1,493,912 shares in the last quarter. 85.47% of the stock is currently owned by institutional investors.

Insider Transactions at Synopsys

In related news, CEO Sassine Ghazi sold 14,603 shares of the business's stock in a transaction on Monday, June 15th. The stock was sold at an average price of $458.96, for a total transaction of $6,702,192.88. Following the sale, the chief executive officer directly owned 75,020 shares in the company, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction on Friday, June 12th. The shares were sold at an average price of $450.02, for a total value of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares of the company's stock, valued at $6,461,387.16. This represents a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold 92,638 shares of company stock worth $40,747,732 over the last quarter. Corporate insiders own 0.56% of the company's stock.

More Synopsys News

Here are the key news stories impacting Synopsys this week:

• Positive Sentiment: Synopsys reported fiscal third-quarter revenue of approximately $2.48 billion and non-GAAP EPS of $3.91, exceeding analyst estimates of $2.44 billion and $3.67, respectively. Revenue grew 42.4% year over year, underscoring continued demand for electronic-design automation and semiconductor IP. Synopsys Results Analysis
• Positive Sentiment: Analysts continue to see significant long-term upside, with reported price targets generally ranging from $450 to $610 and a consensus “Moderate Buy” rating. The bullish case centers on Synopsys’ strategic importance to advanced chip and AI design. Synopsys Wall Street Price Targets
• Neutral Sentiment: Institutional positioning is mixed: 769 investors added SNPS shares in their latest reported quarter, while 764 reduced positions. This suggests continued interest but limited consensus among large investors. Synopsys Institutional Activity
• Negative Sentiment: The earnings beat did not translate into a sufficiently large outlook increase for a stock priced for stronger growth. Full-year guidance implies approximately $9.715 billion of revenue and $15.07 of non-GAAP EPS at the midpoint, prompting a potential “sell-the-news” reaction.
• Negative Sentiment: Investors remain concerned about execution and margin pressure from the Ansys integration. Synopsys reported roughly $236.3 million in restructuring charges during the first nine months of fiscal 2026, while acquired-intangible amortization and approximately $10 billion of debt add to acquisition-related financial risks. Synopsys Ansys Integration Analysis
• Negative Sentiment: Executive Chair Aart de Geus sold 49,641 shares for approximately $21.4 million across August 28, August 31 and September 1. The transactions were made under a pre-arranged Rule 10b5-1 plan, reducing their value as a discretionary bearish signal, but the selling may still weigh on sentiment. Synopsys Insider Selling
• Negative Sentiment: SNPS remains sensitive to higher interest rates and semiconductor-sector weakness. Its valuation remains demanding, with a reported P/E ratio above 69, while the stock is trading below its 200-day moving average. Is Synopsys Stock Underperforming the Nasdaq?

Synopsys Stock Performance

NASDAQ:SNPS opened at $393.84 on Monday. The company has a current ratio of 1.34, a quick ratio of 1.24 and a debt-to-equity ratio of 0.29. The stock has a market capitalization of $75.48 billion, a PE ratio of 69.58, a price-to-earnings-growth ratio of 2.16 and a beta of 1.23. The firm's 50 day moving average is $412.27 and its 200 day moving average is $439.48. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $615.79.

Synopsys (NASDAQ:SNPS - Get Free Report) last released its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%.The business had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period last year, the business posted $3.39 earnings per share. The business's revenue for the quarter was up 42.4% on a year-over-year basis. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. Sell-side analysts expect that Synopsys, Inc. will post 10.97 earnings per share for the current year.

Analyst Ratings Changes

A number of brokerages have issued reports on SNPS. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a research report on Wednesday, May 27th. Morgan Stanley dropped their target price on shares of Synopsys from $525.00 to $500.00 and set an "equal weight" rating on the stock in a research report on Wednesday, August 19th. BNP Paribas Exane upped their target price on Synopsys from $425.00 to $450.00 and gave the company an "underperform" rating in a report on Thursday, May 28th. Weiss Ratings raised Synopsys from a "hold (c-)" rating to a "hold (c)" rating in a research report on Thursday, August 27th. Finally, KeyCorp reiterated an "overweight" rating on shares of Synopsys in a report on Wednesday, August 19th. Twelve equities research analysts have rated the stock with a Buy rating, five have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $561.28.

Synopsys Company Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat

Add MarketBeat as your preferred source on Google to see our latest stories in your feed.

Add As Preferred Source